Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumoniae, systemic inflammation and stable coronary artery disease
Negative results of a case-control study
Albrecht Hoffmeister, MD*,
Dietrich Rothenbacher, MD, MPH ,
Peter Wanner, MS*,
Guenter Bode, PhD ,
Kenneth Persson, MD, PhD ,
Hermann Brenner, MD, MPH ,
Vinzenz Hombach, MD* and
Wolfgang Koenig, MD, FACC*
* Department of Internal Medicine IICardiology, University of Ulm, Ulm, Germany
Department of Epidemiology, University of Ulm, Ulm, Germany
Department of Clinical Microbiology, Malmö General Hospital, University of Lund, Malmö, Sweden
Department of Internal Medicine IGastroenterology, University of Ulm, Ulm, Germany

View larger version (14K):
[in a new window]
|
Figure 1 Distribution of the prevalence of IgG antibodies against Chlamydia pneumoniae by different titres based on microimmunofluorescence (MIF) in cases and controls (n = 791).
|
|
|